Genmab
Julie Blaedel is an experienced leader in the field of medical affairs with a strong focus on oncology and hematology. Currently serving as Vice President of Global Medical Affairs at Genmab, Julie has held prominent roles such as Head of Global Medical Affairs for Hematology and Senior Director, Global Medical Affairs Strategy Lead. Prior experience includes ownership of MD-Consult and roles at Amgen, where Julie served as Medical Director and Clinical Development Lead, as well as positions at GSK and Pfizer in medical advisory capacities. Julie's educational credentials include advanced studies at Harvard Business School and GlaxoSmithKline.
This person is not in any teams
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.